Poly(lactic-co-glycolic acid) (PLGA) Nanoparticles for Drug Delivery
Prashant Kesharwani (Redaktør)
Poly(lactic-co-glycolic acid) (PLGA) Nanoparticles for Drug Delivery is a comprehensive guide to PLGA nanoparticles for targeting
various diseases, covering principles, formation, characterization, applications, regulations and the latest advances. Les mer
- Vår pris
- 3038,-
(Paperback)
Fri frakt!
Leveringstid:
Sendes innen 21 dager
Paperback
Legg i
Paperback
Legg i
Vår pris:
3038,-
(Paperback)
Fri frakt!
Leveringstid:
Sendes innen 21 dager
Poly(lactic-co-glycolic acid) (PLGA) Nanoparticles for Drug Delivery is a comprehensive guide to PLGA nanoparticles for targeting
various diseases, covering principles, formation, characterization, applications, regulations and the latest advances. Sections
introduce the fundamental aspects of PLGA nanoparticles for drug delivery, including properties, preparation methods, characterization,
drug loading methods, and drug release mechanisms, along with a focus on applications. Application of PLGA nanoparticles for
the treatment of cancer, inflammatory, cerebral, cardiovascular, and infectious diseases, as well as in regenerative medicine,
photodynamic and photothermal therapy, and gene therapy, are all explained in detail.
The final chapters explore recent advances and regulatory aspects. This book is a valuable resource for researchers and advanced students across nanomedicine, polymer science, bio-based materials, chemistry, biomedicine, biotechnology, and materials engineering, as well as for industrial scientists and R&D professionals with an interest in nanoparticles for drug delivery, pharmaceutical formulations and regulations, and development of innovative biodegradable materials.
The final chapters explore recent advances and regulatory aspects. This book is a valuable resource for researchers and advanced students across nanomedicine, polymer science, bio-based materials, chemistry, biomedicine, biotechnology, and materials engineering, as well as for industrial scientists and R&D professionals with an interest in nanoparticles for drug delivery, pharmaceutical formulations and regulations, and development of innovative biodegradable materials.
- FAKTA
-
Utgitt:
2022
Forlag: Elsevier - Health Sciences Division
Innbinding: Paperback
Språk: Engelsk
ISBN: 9780323912150
Format: 24 x 19 cm
- KATEGORIER:
- VURDERING
-
Gi vurdering
Les vurderinger
PART A Synthesis and characterization of PLGA nanoparticles for drug delivery 1. History, introduction, and properties of
PLGA nanoparticles as drug delivery carriers 2. Preparation and characterization of PLGA nanoparticles 3. Drug loading methods
and mechanism of drug release from PLGA nanoparticles 4. Biofate and cellular interactions of PLGA nanoparticles
PART B Application of PLGA nanoparticles in drug delivery 5. Targeting strategies using PLGA nanoparticles for efficient drug delivery 6. Current progress in PLGA-based nanoparticles for treatment of cancer diseases 7. PLGA-based nanoparticles for enhanced diagnosis and cancer therapy 8. PLGA-based nanoparticles for the treatment of inflammatory diseases 9. PLGA-based nanoparticles for treatment of cerebral diseases 10. PLGA-based nanoparticles for treatment of cardiovascular diseases 11. PLGA-based nanoparticles for treatment of infectious diseases 12. PLGA-based nanoparticles as regenerative medicine 13. Photodynamic and photothermal therapy using PLGA nanoparticles 14. Gene therapy using PLGA nanoparticles
PART C Recent advances and regulatory aspects in PLGA nanoparticles 15. Hybrid PLGA nanoparticles as advanced drug delivery and theranostic applications 16. Clinical translation of PLGA nanoparticles into the market 17. Biological toxicity and environmental hazards associated with PLGA nanoparticles 18. PLGA nanoparticles: Current uses and emerging trends
PART B Application of PLGA nanoparticles in drug delivery 5. Targeting strategies using PLGA nanoparticles for efficient drug delivery 6. Current progress in PLGA-based nanoparticles for treatment of cancer diseases 7. PLGA-based nanoparticles for enhanced diagnosis and cancer therapy 8. PLGA-based nanoparticles for the treatment of inflammatory diseases 9. PLGA-based nanoparticles for treatment of cerebral diseases 10. PLGA-based nanoparticles for treatment of cardiovascular diseases 11. PLGA-based nanoparticles for treatment of infectious diseases 12. PLGA-based nanoparticles as regenerative medicine 13. Photodynamic and photothermal therapy using PLGA nanoparticles 14. Gene therapy using PLGA nanoparticles
PART C Recent advances and regulatory aspects in PLGA nanoparticles 15. Hybrid PLGA nanoparticles as advanced drug delivery and theranostic applications 16. Clinical translation of PLGA nanoparticles into the market 17. Biological toxicity and environmental hazards associated with PLGA nanoparticles 18. PLGA nanoparticles: Current uses and emerging trends
Dr. Prashant Kesharwani is presently working as an assistant professor at Department of Pharmaceutics, Jamia Hamdard, New
Delhi, India. He is also a receipt of SERB-Ramanujan fellowship (the most prestigious fellowship) from India. Dr. Kesharwani
have academic, industrial and research experience at international level (including USA, Malaysia and India). An overarching
goal of his current research is the development of nano-engineered drug delivery systems for various diseases. Dr. Kesharwani
has more than 300 international publications in well reputed journals and 22 published books (Elsevier). His h-index is 63
and i-10 index is 230 (on April 2023). He is a recipient of several internationally acclaimed awards and research funding
from various funding bodies. He has presented many invited talks and oral presentations at prestigious scientific peer-conferences,
received international acclaims and awards for research contribution, supervised students/junior researchers and actively
participated in outreach and scientific dissemination for the service of wider community.